Streszczenie
4/2024
vol. 99
Wytyczne/zalecenia
Prevention of respiratory syncytial virus infection in children. Recommendations of the Polish Society of Paediatrics and the National Paediatric Consultant
- President of the Polish Paediatric Society
- Department of Paediatrics, Medical Centre for Postgraduate Education, Warsaw, Poland
- Department of Paediatric Endocrinology and Diabetology, Medical University of Lublin, Lublin, Poland
- Department of Gastroenterology and Infant Nutrition, Warsaw Medical University, Warsaw, Poland
- Department of Paediatric Bone Marrow Transplantation, Oncology and Haematology, Medical University of Piastów Śląski, Wrocław, Poland
- Department of Paediatrics, Endocrinology and Paediatric Diabetology, Medical University of Rzeszów, Rzeszów, Poland
- Department of Paediatric Nephrology, Medical University of Piastów Śląski, Wroclaw, Poland
- Department of Paediatrics, Gastroenterology, Allergology and Infant Nutrition, Medical University of Gdańsk, Gdańsk, Poland
- Department of Paediatrics, Haematology and Oncology, A. Jurasz University Hospital No. 1, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- Clinic of Paediatrics, Haematology and Paediatric Oncology, Zabrze, Silesian Medical University, Katowice, Poland
- Department of Paediatric Allergology, Gastroenterology and Nutrition, Medical University, Łódź, Poland
- Clinical Department of Paediatrics with Division of Allergology, Endocrinology, Neurology – Warsaw Children’s Hospital, Dziekanów Leśny, Poland
- College of Medical Sciences, University of Rzeszów, Rzeszów, Poland
- Department of Paediatrics, Oncology and Children’s Immunology, Pomeranian Medical University, Szczecin, Poland
Pediatr Pol 2024; 99 (4): 275-282
Data publikacji online: 2024/12/30
Słowa kluczowe
respiratory syncytial virus, RSV, palivizumab, Abrysvo, nirsevimab
Zintergrowane z
